The use of explant lens culture to assess cataractogenic potential

Annals of the New York Academy of Sciences

Volumn 919, Issue 1, 2000, Pages 171-187

  Aleo, Michael D ^a   Avery, Michael J ^a   Beierschmitt, William P ^a   Drupa, Cynthia A ^a   Fortner, Jay H ^a   Kaplan, Adam H ^a   Navetta, Kimberly A ^a   Shepard, Richard M ^a   Walsh, Colleen M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(1,2 DICHLOROVINYL)CYSTEINE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 1 METHYL 2 QUINOLONE; AMINOOXYACETIC ACID; CIGLITAZONE; CJ 12 918; CJ 13 454; CYSTEINE CONJUGATE BETA LYASE; CYSTEINE DERIVATIVE; DARGLITAZONE; ENGLITAZONE; TETRAHYDROPYRAN DERIVATIVE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL TISSUE; CATARACT; CATARACTOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; EXPLANT; LENS; MALE; MICROSOME; MODEL; NONHUMAN; RAT; TOXICOKINETICS;

ANIMALIA;

EID: 0033710991     PISSN: 00778923     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-6632.2000.tb06877.x     Document Type: Article

References (29)

1. Cataract formation after triparanol therapy
2. Cataracts produced by triparanol (MER/29)
3. Cataracts in patients treated with triparanol
4. Effects of the slow calcium-channel blocker verapamil on phosphatic metabolism of crystalline lens
5. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats
6. Preclinical evaluation of lovastatin
7. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens
8. Amizol-induced cataract and inhibition of lens catalase in rabbit
9. 2, and/or OH
10. The lens in diabetes
11. The effectiveness of putative anti-cataract agents in the prevention of protein glycation
12. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains
13. Mechanistic analysis of S-(1,2-dichlorovinyl)-L-cysteine-induced cataractogenesis in vitro
14. Aldose reductase catalyzes the oxidation of naphthalene-1,2-dihydrodiol for the formation of ortho-naphthoquinone
15. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice
16. [[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents
17. A new potentiator of insulin action: Post-receptor activation in vitro
18. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase
19. Ciglitazone reverses cAMP-induced post-insulin receptor resistance in rat adipocytes in vitro
20. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone
21. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
22. 'Glitazones', a prospect for non-insulin-dependent diabetes
23. A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats
24. Mechanisms of ciglitazone-induced cataractogenesis [abstract]
25. Chronic toxicity of S-(trans-1,2-dichlorovinyl)-L-cysteine in mice
26. 1 cells
27. Role of desacetylation in the detoxification of cephalothin in renal cells in culture
28. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (AL01576)
29. Tamoxifen blocks chloride channels: A possible mechanism for cataract formation